Niva Bupa lists at 6% premium

Niva Bupa Share Price & IPO Listing Highlights: Niva Bupa shares drop after listing at 6% premium
Shares of Niva Bupa were listed on stock exchanges today at 5.5-6% premium over the IPO price of ₹74. However, the stock closed at ₹74.01 on the NSE and at ₹74 on the BSE. The IPO of Niva Bupa Health Insurance Company Ltd,
Niva Bupa Shares Drop 5.6% On BSE After Listing At 6% Premium; Check Details
Niva Bupa Health Insurance Company's shares debuted on the stock market on Thursday (November 14), opening at a 6 per cent premium over its issue price. However, the shares of the company experienced a decline in midday trading,
Niva Bupa lists at 6% premium; shares debut at Rs 78.50 on BSE
Niva Bupa Health Insurance Company had a positive listing debut on November 14, 2024, with its shares trading above the IPO issue price on both the NSE and BSE. The stock opened at Rs 78.14 on the NSE, a premium of 5.59 percent, while on the BSE, it quoted Rs 78.50, marking a 6.08 percent jump from the issue price of Rs 74.
Niva Bupa shares tumble over 6% post listing, erasing gains. What investors should do
Niva Bupa shares debuted at Rs 78.5 on the BSE, a 6.1% premium over the issue price, and at Rs 78.1 on the NSE, slightly exceeding expectations. Supported by strong retail investor demand, Niva Bupa Healthcares IPO successfully closed on the final day of bidding.
Niva Bupa makes subdued debut, lists at 5.5% premium on NSE
Niva Bupa IPO listing price: The allotment of the issue was finalised on November 12 by the registrar of the issue. (Image: Freepik) Niva Bupa IPO listing price: Niva Bupa hit the bourses on a lacklustre note, listing at Rs 78.14 on the NSE, a premium of 5 ...
Niva Bupa Health Insurance share price dips after positive debut. Buy, sell or hold?
Niva Bupa Health Insurance shares opened on the BSE at ₹78.50 apiece and touched an intraday high of ₹80.94 apiece
Niva Bupa shares slip 2% post premium listing
Niva Bupa Health Insurance Company shares declined 1.95 per cent to ₹76.62 on NSE by 10.30 am on Thursday, after listing at a premium earlier in the day. The stock debuted at ₹78.14 on NSE and ₹78.50 on BSE, marking a 5.5-6 per cent premium over its issue price of ₹74.
Niva Bupa Share Price Highlights: Niva Bupa lists at Rs 78.14, premium of 5.5% on NSE
Niva Bupa Health Insurance IPO is all set to list on November 13. The IPO was subscribed to a total of 1.9 times while the retail portion was booked 2.88 times. The stock of Niva Bupa was neither fetching a premium nor a discount from the grey market, indicating a lacklustre debut for the stock on the bourses.
Niva Bupa Health Insurance shares list at ₹78.14 on NSE, a premium of 5.5% from IPO price
Niva Bupa Health Insurance shares made a decent debut on the bourses on Thursday, November 14 as they listed at ₹78.14 on NSE, a premium of 5.5 percent over the issue price of ₹74. Meanwhile, on BSE,
Healthy Listing: Niva Bupa Health Shares Make A Debut At Mild Premium From IPO Price On Exchanges; BUY?
Niva Bupa Health Insurance Company Ltd, formerly known as Max Bupa Health Insurance, made its entry into the stock market on November 14, opening at a decent premium, even as experts predicted a subdued listing.
Niva Bupa share price dips over 3% after rising into the green on debut, See details of its ₹2,200 crore IPO
Niva Bupa share price opened at a 6% premium over its upper IPO price band after its listing, following a subscription of 1.80 times for its ₹2,200 crore IPO
Mint8h
Niva Bupa Health Insurance IPO listing date today. What GMP, experts indicate about share debut
Niva Bupa Health Insurance IPO Listing: Niva Bupa Health Insurance shares are set to market stock market debut today, ...
moneycontrol.com7h
Stock Radar: Eicher Motors, Niva Bupa, Cipla, Zomato, Nykaa, Varun Beverages, Vodafone Idea, NALCO in focus on Thursday
The company has opened its Qualified Institutions Placement (QIP) issue on November 13. The floor price has been fixed at Rs ...
Niva Bupa’s IPO to boost solvency, power future expansion: Krishnan Ramachandran
We have been investing in distribution, in talent, in products, in technology, in our brand over the last few years, so for ...